GURU.Markets stock price, segment price, and overall market index valuation
The company's share price CareDx Inc
CareDx specializes in diagnostic tests for organ transplant patients. Its stock price reflects the growth of the transplant market and the introduction of its tests to monitor organ rejection. The chart highlights both innovation and regulatory risks.
Share prices of companies in the market segment - Medanalysis
CareDx is an innovative company specializing in diagnostic solutions for organ transplant patients. We've classified it in the "Medical Analysis" segment because its technologies are vital. The chart below shows how the market as a whole views the prospects of companies in the medical diagnostics sector.
Broad Market Index - GURU.Markets
CareDx is an innovative company specializing in diagnostic solutions for organ transplant patients. As a key player in the healthcare sector, it is included in the GURU.Markets index. The chart below compares its performance to the overall US market.
Change in the price of a company, segment, and market as a whole per day
CDNA - Daily change in the company's share price CareDx Inc
The daily price change of CareDx, a company specializing in organ transplant diagnostics, reflects innovation in this field. Change_co measures high volatility associated with regulatory decisions and competition. This metric is an important element for analyzing companies in the personalized medicine sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
CareDx, Inc. is a company in the field of transplant diagnostics. This chart highlights the high volatility of the sector. Comparing it to CDNA, whose business depends on transplant volume and insurance rates, helps assess its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
CareDx is a company specializing in diagnostic tests for organ transplant patients. This sector is one of the most advanced and volatile in biotech. The chart below reflects the extreme fluctuations typical of this industry.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization CareDx Inc
CareDx is a leader in diagnostics for organ transplant patients. Its year-over-year growth reflects rapid growth in testing volumes and investor confidence in the potential of its technologies to improve patient care.
Annual dynamics of market capitalization of the market segment - Medanalysis
CareDx, Inc. is a company specializing in diagnostic solutions for organ transplant patients. Its tests help monitor rejection. The graph shows how its dominant position in this important medical niche and changes in the reimbursement system are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
CareDx, which specializes in diagnostics for transplant patients, operates in the defensive healthcare sector. Demand for its tests is unaffected by economic cycles. The company's stock performance reflects its success in commercialization and innovation, making it a growth story isolated from general market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization CareDx Inc
CareDx, a company specializing in diagnostics for organ transplant patients, has monthly fluctuations in the chart reflecting the volume of organ rejection monitoring tests performed, as well as changes in reimbursement rates from public and private insurers, which directly impacts its revenue.
Monthly dynamics of market capitalization of the market segment - Medanalysis
CareDx specializes in diagnostic services for organ transplant patients. This is a niche, high-tech service within the healthcare sector. The dynamics of this segment reflect not only general trends in medicine but also specific breakthroughs in genomics and personalized medicine. The chart shows how the market has valued these innovations.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
CareDx offers diagnostic tests for organ transplant patients. It is a highly specialized medical company. Its stock price is driven by the number of tests performed and insurance rates, rather than macroeconomic indicators, demonstrating its independence from general market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization CareDx Inc
CareDx specializes in diagnostics for organ transplant patients. The company's weekly stock price is highly sensitive to news about changes in Medicare reimbursement rates and data confirming the clinical value of its tests.
Weekly dynamics of market capitalization of the market segment - Medanalysis
CareDx is a company specializing in diagnostics for transplant patients. Comparing its weekly performance with the healthcare sector reveals its uniqueness. The chart clearly demonstrates how regulatory decisions on Medicare rates are causing its shares to take on a life of their own, separate from general industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of CareDx, a diagnostics company, exist in a world of their own, far removed from macroeconomic news. Their performance is determined by the decisions of insurance companies. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can move independently of the broader market.
Market capitalization of the company, segment and market as a whole
CDNA - Market capitalization of the company CareDx Inc
CareDx's market capitalization chart reflects the state of the transplant diagnostics market. The company provides tests for monitoring organ rejection. Its volatile dynamics reflect how investors react to changes in Medicare reimbursement rules, competition, and new research results.
CDNA - Share of the company's market capitalization CareDx Inc within the market segment - Medanalysis
CareDx is a company specializing in diagnostic tests for organ transplant patients that help monitor rejection. Its market share in the healthcare analytics sector reflects its dominance in this vital niche. The chart below shows the weight of this leader in transplant patient health monitoring.
Market capitalization of the market segment - Medanalysis
CareDx specializes in diagnostic tests for organ transplant patients, helping to monitor rejection. The chart below shows the overall market capitalization of the medical testing sector. It reflects the importance of personalized medicine and accurate monitoring, which improve treatment outcomes and save lives.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph shows the cost of donor organ care. CareDx provides diagnostic services for monitoring transplant rejection. Its market cap is a barometer of the development of transplantation. The company's growth means more patients have a chance at a long life after surgery.
Book value capitalization of the company, segment and market as a whole
CDNA - Book value capitalization of the company CareDx Inc
CareDx's book value is based on its technologies and laboratories for testing organ rejection in transplant patients. This represents scientific and material capital that saves lives. The chart shows how the commercialization of these unique diagnostic services has shaped the company's capital base.
CDNA - Share of the company's book capitalization CareDx Inc within the market segment - Medanalysis
CareDx is a key player in the field of diagnostics for transplant patients. Its strength lies in its network of specialized, high-tech laboratories that perform unique tests. The chart shows the company's control over the entire physical laboratory infrastructure in this vital medical niche.
Market segment balance sheet capitalization - Medanalysis
CareDx's transplant diagnostics require high-tech laboratories. Compared to its healthcare sector assets, this makes the company moderately capital-intensive. Its tests require complex and expensive physical infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
CareDx's assets are high-tech laboratories that conduct tests to monitor patients after organ transplants. The book value reflects the physical infrastructure and equipment required to provide these vital diagnostic services. The chart illustrates the company's scale in the transplant niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - CareDx Inc
CareDx is valued by the market far above the value of its laboratories. This premium reflects its dominant position in the organ transplant testing market, its recurring revenue model, and its potential to expand into other diagnostic areas.
Market to book capitalization ratio in a market segment - Medanalysis
CareDx specializes in diagnostic tests for organ transplant patients. It's a high-tech medical business. The chart shows how investors value its unique technology and dominant position in its niche, placing a high premium on its book value.
Market to book capitalization ratio for the market as a whole
CareDx specializes in diagnostic services for organ transplant patients. Its tests help monitor organ rejection. This is a niche but critically important market. This metric demonstrates the premium investors are willing to pay for leadership in high-tech medicine, where the company is setting the standard for patient care.
Debts of the company, segment and market as a whole
CDNA - Company debts CareDx Inc
CareDx, which specializes in diagnostics for organ transplant patients, uses debt to fund the research, development, and commercialization of its tests. This chart shows how the company is investing in maintaining its technological leadership and expanding its market presence, which requires significant financial infusions.
Market segment debts - Medanalysis
CareDx is a company specializing in diagnostic solutions for organ transplant patients. Its tests help monitor the condition of the transplanted organ. This rapidly growing medical sector requires investment in R&D and commercialization. The chart shows how CareDx is funding its growth and how its financial policies reflect its ambition to become the standard in transplant care.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio CareDx Inc
CareDx specializes in diagnostic tests for organ transplant patients. This is a highly technological area of medicine that requires continuous research and development to improve accuracy and develop new tests. This chart shows how the company uses debt to fund innovation, a key factor in its competitive advantage.
Market segment debt to market segment book capitalization - Medanalysis
CareDx specializes in diagnostic tests for organ transplant patients, a high-tech segment of medicine. This chart shows how the company finances its research and commercialization of tests. It compares its debt load to the market capitalization of the entire medical diagnostics sector, reflecting its financial strategy.
Debt to book value of all companies in the market
CareDx specializes in diagnostic tests for organ transplant patients. This is a high-tech medical field where innovation and research are critical. How heavily does the company rely on debt to finance its operations? This chart of total debt in the economy allows us to assess the risks of its financial strategy compared to the market.
P/E of the company, segment and market as a whole
P/E - CareDx Inc
CareDx is a company specializing in diagnostic services for organ transplant patients. This chart shows how investors value its organ rejection monitoring tests. The high valuation reflects its leadership in this niche but critical market and the potential for expanded application of its technologies.
P/E of the market segment - Medanalysis
CareDx is a company specializing in high-tech solutions for diagnostics and monitoring the health of patients after organ transplants. Its tests help doctors detect rejection at an early stage. This chart shows the average rating for the medical analytics sector, which helps understand the market premium placed on CareDx's innovative technologies.
P/E of the market as a whole
CareDx specializes in diagnostic tests for organ transplant patients. This is a rapidly growing and important market. Does the company's high valuation reflect a general interest in the medical diagnostics sector, or is it a unique belief in its leadership and ability to protect its technology from competitors? This chart helps illustrate how its story stands out.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company CareDx Inc
CareDx is a company specializing in diagnostic tests for organ transplant patients. Its tests help doctors monitor the condition of the transplanted organ. This chart shows market expectations for future revenue, which depend on the widespread use of its tests in medical practice and insurance reimbursement.
%20P%2FE%20CareDx%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-CareDx-Inc&v=1772647532771 "Chart of the company's future (projected) P/E CareDx Inc")
Future (projected) P/E of the market segment - Medanalysis
CareDx specializes in diagnostic services for organ transplant patients. Its tests help monitor transplant rejection, a vital aspect for recipients. The chart shows forecasts for the entire medical diagnostics industry, allowing one to assess the market's confidence in CareDx's leadership in its narrow but critical niche.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772647532854 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
CareDx, Inc. specializes in diagnostic tests for organ transplant patients. This is a fast-growing market in the field of personalized medicine. This market sentiment chart is important because it shows how willing investors are to invest in innovative medical technologies with strong growth potential.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772647533008 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit CareDx Inc
CareDx specializes in diagnostic tests for organ transplant patients. The company's revenue is directly dependent on the number of tests performed, which help doctors monitor the patient's condition. This chart reflects the growth of the transplant market and the successful commercialization of CareDx's unique medical technologies.
Profit of companies in the market segment - Medanalysis
CareDx specializes in diagnostic services for organ transplant patients, helping to monitor rejection. This chart, reflecting the profitability of the medical analytics sector, demonstrates the growing importance of personalized medicine. CareDx's success is directly related to the increasing number of transplants and the adoption of their highly accurate tests in clinical practice.
Overall market profit
CareDx specializes in diagnostic tests for organ transplant patients, helping to monitor rejection. The company's success depends on overall healthcare spending and innovation. Economic growth, reflected in corporate profit growth, facilitates increased funding for healthcare institutions, enabling them to utilize CareDx's cutting-edge tests.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company CareDx Inc
CareDx specializes in diagnostic services for organ transplant patients. Their tests help doctors monitor the condition of the transplanted organ and the risk of rejection. This chart shows analysts' forecasts for the number of tests performed and the adoption of their technologies in clinical practice, which directly impacts the company's revenue.
%20profit%20of%20the%20company%20CareDx%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-CareDx-Inc&v=1772647533437 "Graph of future (projected) profit of the company CareDx Inc")
Future (predicted) profit of companies in the market segment - Medanalysis
CareDx is a company specializing in diagnostic solutions for organ transplant patients. Its growth is driven by the adoption of its tests in clinical practice. The projected profitability for the entire medical diagnostics sector, shown in the graph, reflects overall trends in healthcare spending and the adoption of innovative personalized technologies.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772647533585 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
CareDx specializes in diagnostics for organ transplant patients. Its business is less dependent on short-term economic fluctuations. However, the overall economic situation reflected in this forecast impacts public and private healthcare funding, which is important for the company's long-term growth.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772647533640 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - CareDx Inc
CareDx is a leading diagnostic company for organ transplant patients. This chart demonstrates the high valuation of each dollar of its revenue. Investors see enormous potential in its unique tests, which are becoming the standard in medicine, and are willing to pay for market leadership and future revenue growth from vital services.
P/S market segment - Medanalysis
CareDx specializes in diagnostic services for organ transplant patients, helping to monitor the health of the transplant. The company's revenue grows with the increasing number of procedures and the introduction of its tests. This chart reflects the average valuation in the medical diagnostics sector, providing context for understanding how the market values CareDx's unique niche and technology.
P/S of the market as a whole
CareDx is a company specializing in diagnostic services and products for organ transplant patients. Its business operates at the intersection of medicine and data. This chart, showing the average price-to-sales ratio for the entire market, helps assess how highly investors value CareDx's unique niche and its lifesaving potential, expressed in financial multiples.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company CareDx Inc
CareDx is a company specializing in diagnostic services for organ transplant patients. Its goal is to improve treatment outcomes. This indicator reflects how the market perceives the company's future growth through the wider adoption of its tests and the development of new diagnostic products that could become standard in medicine.
%20P%2FS%20CareDx%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-CareDx-Inc&v=1772647534061 "The graph of the company's future (projected) P/S CareDx Inc")
Future (projected) P/S of the market segment - Medanalysis
CareDx, Inc. is a company specializing in the development and commercialization of diagnostic solutions for organ transplant patients. Its tests help monitor the health of transplant recipients. This chart shows the average estimated future revenue in the medical diagnostics sector. It provides an opportunity to assess how the market perceives CareDx's growth prospects compared to other innovative companies.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772647534074 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
CareDx specializes in diagnostic tests for organ transplant patients, helping to monitor the risk of rejection. This chart reflects overall investor sentiment. CareDx's success demonstrates how innovations in personalized medicine not only save lives but also create new markets, contributing to overall revenue growth expectations in the healthcare sector.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772647534085 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales CareDx Inc
This chart illustrates the sales of CareDx, Inc., a company specializing in high-tech diagnostic solutions for transplantation. Its revenue is generated from sales of tests that help monitor the health of transplanted organs. The dynamics in this chart reflect the growth in transplantation rates and the adoption of its innovative monitoring methods in clinical practice.
Sales of companies in the market segment - Medanalysis
CareDx, Inc. is a company specializing in the development and commercialization of diagnostic solutions for organ transplant patients. This chart shows the dynamics of the high-tech diagnostics market. CareDx's organ rejection monitoring products have become industry standards, and their widespread use directly increases the overall transplant market.
Overall market sales
CareDx specializes in diagnostic testing for organ transplant patients. Demand for its services is driven by the number of surgeries and the need for monitoring. Overall economic activity, shown in this graph, influences healthcare system funding and access to high-tech medical care.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company CareDx Inc
CareDx specializes in diagnostic services for organ transplant patients. The company's future revenue depends on the number of transplants and the adoption of its tests in clinical practice. This chart shows analysts' forecasts for transplant market growth and the adoption of innovations.
%20sales%20of%20the%20company%20CareDx%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-CareDx-Inc&v=1772647534253 "Schedule of future (projected) sales of the company CareDx Inc")
Future (projected) sales of companies in the market segment - Medanalysis
CareDx specializes in diagnostic services for organ transplant patients. Its tests help doctors monitor the condition of the transplant and prevent rejection. This chart shows the forecast for the medical diagnostics market, where CareDx occupies a critical and rapidly growing niche in patient health monitoring.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772647534313 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
CareDx provides diagnostic testing services for organ transplant patients. Demand for their services is non-cyclical, driven by the number of surgeries rather than the state of the economy. While this chart reflects general economic fluctuations, CareDx's business demonstrates the stability typical of key healthcare sectors.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772647534337 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality CareDx Inc
CareDx specializes in diagnostic services for organ transplant patients. Its profitability depends on the number of tests performed and their reimbursement by insurance companies. This chart shows how the company monetizes its unique genomics technologies, turning patient health monitoring into a sustainable business model.
Market segment marginality - Medanalysis
CareDx is a leading company in diagnostics for organ transplant patients. Their tests help monitor the health of the transplanted organ and the risk of rejection. Profitability depends on the widespread adoption of their diagnostic services. This chart shows their operating results. Their superiority over competitors speaks to the strength of their technology and their position in the transplant market.
Market marginality as a whole
CareDx is a company specializing in diagnostic services for organ transplant patients. Their tests help monitor the health of the transplanted organ and the risk of its rejection. This overall profitability curve has little impact on their business. Demand for their services is determined by the number of transplants and medical protocols, not the state of the economy.
Employees in the company, segment and market as a whole
Number of employees in the company CareDx Inc
CareDx provides vital diagnostic services for organ transplant patients. Its team includes laboratory technicians, scientists, and a sales team dedicated to serving transplant centers. The growth in this chart is directly related to increased testing volumes and the recognition of its products by the medical community.
Share of the company's employees CareDx Inc within the market segment - Medanalysis
CareDx is a leader in diagnostic services for organ transplant patients. This chart reflects the company's workforce in the high-tech medical sector. This growth reflects the expansion of its laboratory capacity and scientific teams, which develop and administer tests vital for thousands of recipients worldwide.
Number of employees in the market segment - Medanalysis
CareDx, Inc. is a company specializing in diagnostic solutions for organ transplant patients. This chart illustrates employment trends in the high-tech field of transplant monitoring. The growth in the number of specialists here reflects advances in personalized medicine and the introduction of non-invasive tests that significantly improve patients' quality of life.
Number of employees in the market as a whole
CareDx is a leading company in diagnostics for organ transplant patients. Its tests help doctors monitor the condition of transplanted organs and prevent rejection. This figure demonstrates how the breakthroughs in personalized medicine and diagnostics offered by CareDx are creating demand for specialists in biotechnology and laboratory research.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company CareDx Inc (CDNA)
CareDx specializes in diagnostic services for organ transplant patients. This chart reflects the high value of its intellectual capital. The company's main assets are its patented testing technologies (such as AlloSure) and accumulated data. The chart shows how highly the market values these unique diagnostic products and their market potential per employee.
%20of%20the%20company%20CareDx%20Inc%20(CDNA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-CareDx-Inc-CDNA&v=1772647534761 "Chart of market capitalization per employee (in thousands of dollars) of the company CareDx Inc (CDNA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
CareDx specializes in diagnostic services for organ transplant patients. This is a high-tech niche in medicine, based on scientific research. This chart demonstrates the high valuation of the company's unique diagnostic tests and technologies. The company's pricing is driven by a small team of scientists and technicians, reflecting its high per-employee ratio.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772647534836 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
CareDx is a company specializing in diagnostic services for organ transplant patients. This chart shows how the market values this niche medical leader. Its high cost per employee reflects the value of its unique tests, which help doctors monitor transplant rejection and improve patient outcomes.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772647534884 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company CareDx Inc (CDNA)
CareDx is a company specializing in high-tech diagnostic solutions for organ transplant patients. Their tests help monitor rejection. It's a business at the intersection of medicine and data. This chart shows how the company monetizes its unique tests. Their efficiency is driven by high margins on diagnostic services and a growing patient base.
%20Chart%20CareDx%20Inc%20(CDNA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-CareDx-Inc-CDNA&v=1772647534912 "Company Profit Per Employee (in thousands of dollars) Chart CareDx Inc (CDNA)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
CareDx (CDNA) is a company specializing in diagnostics for organ transplant patients. Their tests (AlloSure, AlloMap) help monitor rejection. This is a high-margin diagnostic business. This metric reflects how successfully their laboratories and sales team promote these vital tests.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772647534950 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
CareDx is a biotech company specializing in diagnostic tests for organ transplant patients (rejection). It offers niche R&D and services. This chart shows the demand for their unique tests (AlloSure, AlloMap). It reflects the profit margins of these tests based on the number of scientists and technicians employed.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772647534954 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee CareDx Inc (CDNA)
CareDx specializes in diagnostic services for organ transplant patients. This chart demonstrates the demand for its unique tests. The growth in revenue per employee reflects the increasing number of tests performed, the expansion of its client base among clinics, and the high value of its diagnostic solutions in medicine.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-CareDx-Inc-CDNA&v=1772647534967 "Sales chart per company employee CareDx Inc (CDNA)")
Sales per employee in the market segment - Medanalysis
CareDx is at the intersection of medicine and data, offering tests for monitoring the health of transplanted organs. This chart shows how productive their team is, from the lab technicians processing the tests to the R&D specialists. It measures revenue per employee, comparing their efficiency with other companies in the medical diagnostics sector.
Sales per employee for the market as a whole
CareDx (CDNA) specializes in high-tech diagnostic solutions for organ transplant patients. Their tests help monitor rejection. It's a knowledge-intensive business. This chart shows how effectively the company is monetizing its unique diagnostic services. The growth in this indicator indicates the successful implementation of their tests in clinical practice.
Short shares by company, segment and market as a whole
Shares shorted by company CareDx Inc (CDNA)
CareDx, Inc. is a company specializing in diagnostic services for organ transplant patients, helping to monitor rejection. The bearish sentiment reflected in this chart may be due to regulatory pressure on reimbursement for its tests or the emergence of new, cheaper, or more effective diagnostic methods in this highly specialized area.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-CareDx-Inc-CDNA&v=1772647535181 "Short Shares Chart for the Company CareDx Inc (CDNA)")
Shares shorted by market segment - Medanalysis
CareDx is a company that provides diagnostic tests for organ transplant patients (to monitor rejection). This chart shows bearish bets. "Short" bets here are bets that their tests are ineffective or (more importantly) that Medicare will reduce reimbursement for them.
Shares shorted by the overall market
CareDx specializes in life-saving diagnostics for transplant patients. This chart reflects the overall level of investor anxiety. In times of panic, even the healthcare sector isn't immune. The question for CareDx: is their highly specialized medical business a safe haven, or will it too be swept up in the wave of general pessimism?
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator CareDx Inc (CDNA)
CareDx provides diagnostic tests for organ transplant patients. Business depends on transplant volume and reimbursement rates. A chart above 70 may reflect strong growth in testing. A range below 30 is often associated with competition concerns or reimbursement issues with insurers.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-CareDx-Inc-CDNA&v=1772647535337 "RSI 14 indicator chart for the company's stock CareDx Inc (CDNA)")
RSI 14 Market Segment - Medanalysis
CareDx (CDNA) — transplant monitoring. Their tests (AlloSure, AlloMap) help doctors track *rejection* of transplanted organs (heart, kidney). RSI_14_Seg for "Medanalysis" (diagnostics) shows the "temperature" in this cutting-edge sector. The graph helps us understand: is CDNA's growth a niche product or a general "overheating"?
RSI 14 for the overall market
CareDx (CDNA) provides transplant monitoring tests. This chart shows that its business is "defensive." Demand for these tests isn't dependent on euphoria or panic—it's a matter of life and death. During times of market panic, investors seek safe havens in companies with completely non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CDNA (CareDx Inc)
CareDx (CDNA) specializes in diagnostic services for organ transplant patients. Their tests (such as AlloSure) help monitor organ rejection without invasive biopsy. This chart shows the average analyst forecast. Their target prices depend on testing volume and, crucially, Medicare reimbursement decisions for these tests.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CDNA-CareDx-Inc&v=1772647535493 "A chart showing analyst consensus forecasts for the expected stock price. CDNA (CareDx Inc)")
The difference between the consensus estimate and the actual stock price CDNA (CareDx Inc)
CareDx (CDNA) is a leader in diagnostics for organ transplant patients. Their blood tests (AlloSure, AlloMap) help detect rejection. This chart shows their market share. It measures the gap between their price and the consensus target, reflecting whether analysts believe they will dominate the transplant monitoring market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CDNA-CareDx-Inc&v=1772647535551 "A chart showing the difference between the consensus forecast and the actual stock price. CDNA (CareDx Inc)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
CareDx (CDNA) is a company specializing in diagnostics for organ transplant patients. Its tests (AlloSure, AlloMap) help monitor transplant rejection. This chart shows general expectations for the medical testing sector. It reflects whether experts believe the high-tech patient monitoring market will grow.
Analysts' consensus forecast for the overall market share price
CareDx (CDNA) is a company focused on organ transplant health. Their diagnostic tests (AlloSure, AlloMap) help doctors monitor the risk of kidney or heart rejection without invasive biopsy. This chart shows overall risk appetite, reflecting the market's confidence in companies changing medical standards through high-cost innovations.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index CareDx Inc
CareDx is a leader in transplant health. Their business consists of high-tech diagnostic tests (like AlloSure) that use a patient's blood to determine whether a transplanted organ (kidney, heart) is being rejected. This chart is a barometer of their niche. It likely reflects the pace of adoption of their tests and, crucially, regulatory decisions regarding their reimbursement (Medicare rates).
AKIMA Market Segment Index - Medanalysis
CareDx (CDNA) is a leader in transplant diagnostics; the company dominates in providing tests (AlloSure, AlloMap) that help doctors monitor the risk of organ rejection. This summary metric evaluates R&D. The graph shows the average value for the segment. This benchmark: how does this unique niche monopoly (CDNA) differentiate itself from the average competitor?
The AKIM Index for the overall market
CareDx is a leader in diagnostics for organ transplant patients. The company provides tests and services for monitoring transplant health. This chart, which reflects the market average, provides context. It helps assess how this specialized healthcare business, dependent on transplant volumes, compares to overall macroeconomic trends.
